Efficacy and Safety of Pre-Endoscopy Regimens for Mucosal Visualization During Sedated Esophagogastro-duodenoscopy: A Randomized Controlled Trial
Keywords:
esophagogastroduodenoscopy, mucosa visibility, premedication, simethicone, N-acetylcysteineAbstract
Background: Optimal mucosal visibility during esophagogastroduodenoscopy (EGD) is critical for diagnostic accuracy but is often impaired by the presence of mucus and bubbles. This study aimed to compare the efficacy and safety of four premedication regimens for mucosal visualization during sedated EGD. Methods: A double-blind randomized controlled trial was conducted at the Endoscopy Unit of Dr. Zainoel Abidin General Hospital, Banda Aceh, Indonesia, from January to December 2024. Patients scheduled for elective diagnostic EGD were randomly assigned to: Group 1 (simethicone 40 mg at 30 minutes before the procedure), Group 2 (simethicone 40 mg + 100 mL 5% sodium bicarbonate at 2 hours), Group 3 (simethicone 40 mg + N-acetylcysteine 600 mg in 100 mL water at 2 hours), or Group 4 (all three agents at 2 hours). Primary outcomes were mucosal visibility (6-site, 3-point scoring system with lower scores indicating superior mucosal visibility); procedural metrics (irrigation volume and duration); and safety (the lowest recorded SpO₂%). Data were analyzed using ANOVA or Kruskal–Wallis for continuous variables, and Chi-square or Fisher’s exact test for categorical variables, with post hoc testing as applicable. Results: A total of 168 patients were randomized into four groups (n=42 each). Groups 3 and 4 showed superior mucosal visibility compared to Groups 1 and 2 (p=0.004), with no significant difference between Groups 3 and 4. Irrigation volume differed significantly (p=0.018), lowest in Group 4. Group 3 had the shortest procedure time (3.1 ± 1.2 minutes), significantly more efficient than Groups 1 and 2, but similar to Group 4. Oxygen saturation was slightly lower in Group 3 (p<0.005), though all groups remained within safe clinical limits. Conclusions: Simethicone and N-acetylcysteine given two hours before endoscopy effectively enhanced mucosal visibility and procedural efficiency without compromising safety, offering a practical alternative to more complex regimens.References
Park WG, Shaheen NJ, Cohen J, et al. Quality indicators for EGD. Gastrointest Endosc 2015;81 (1):17-30.
Kim SY, Park JM. Quality indicators in esophagogastroduodenoscopy. Clin Endosc. 2022;55 (3):319-31.
Loganathan P, Gajendran M, Perisetti A, et al. Endoscopic advances in the diagnosis and management of gastroesophageal reflux disease. Medicina (Kaunas). 2024;60 (7).
Gibiino G, Binda C, Secco M, et al. Endoscopic management of bleeding in altered anatomy after upper gastrointestinal surgery. Medicina (Kaunas). 2023;59 (11).
Vu TB, Tran TNQ, Tran TQA, Vu DL, Hoang VT. Antibiotic resistance of Helicobacter pylori in patients with peptic ulcer. Medicina (Kaunas). 2022;59 (1).
Lee J, Lee I, Oh Y, et al. Current status of anti-reflux surgery as a treatment for GERD. Medicina (Kaunas). 2024;60 (3).
Mari A, Abu Baker F, Said Ahmad H, et al. The yield of endoscopy and histology in the evaluation of esophageal dysphagia: Two referral centers' experiences. Medicina (Kaunas). 2021;57 (12).
Yadlapati R, Early D, Iyer PG, et al. Quality indicators for upper GI endoscopy. Gastrointestinal Endoscopy. 2025;101 (2):236-60.
Linares-Ramírez JD, Córdoba AC, Calderón-Franco C H, et al. Premedication in upper gastrointestinal endoscopy to improve mucosal visualization. A systematic review. Revista de Gastroenterología del Perú. 2024;44 (4):346-53.
Kim GH, Cho YK, Cha JM, Lee SY, Chung IK. Efforts to increase image quality during endoscopy: The role of pronase. World J Gastrointest Endosc. 2016;8 (5): 267-72.
Sadeghi V, Vard A, Sharifi M, Mir H, Mehridehnavi A. Segmentation and region quantification of bubbles in small bowel capsule endoscopy images using wavelet transform. Informatics in Medicine Unlocked. 2023;42.
Hammoud GM. Endoscopic assessment and management of early esophageal adenocarcinoma. World Journal of Gastrointestinal Oncology. 2014;6 (8).
Waddingham W, Graham DG, Banks MR. Latest advances in endoscopic detection of oesophageal and gastric neoplasia. Diagnostics (Basel). 2024;14 (3).
Park JY. Image-enhanced endoscopy in upper gastrointestinal disease: focusing on texture and color enhancement imaging and red dichromatic imaging. Clin Endosc. 2025;58 (2):163-80.
Basford PJ, Brown J, Gadeke L, et al. A randomized controlled trial of pre-procedure simethicone and N-acetylcysteine to improve mucosal visibility during gastroscopy-NICEVIS. Endosc Int Open. 2016;4 (11): E1197-E1202.
Ullmann O, Ranti D, Georgiadou E, Hillemacher T, Schmidt A, von Hahn T. Provider-reported use of butylscopolamine in gastrointestinal endoscopy in Germany. Endosc Int Open. 2024;12 (1):E36-E42.
Chen X, Dai N, Deng Y, et al. Premedication with reformulated simethicone and sodium bicarbonate improves mucosal visibility during upper gastrointestinal endoscopy: a double-blind, multicenter, randomized controlled trial. BMC Gastroenterol. 2021;21 (1):124.
Gualandi N, Gibiino G, Bonura GF, et al. A novel cleansing solution for high-quality upper gastrointestinal endoscopy: A multicenter randomized controlled trial. Techniques and Innovations in Gastrointestinal Endoscopy. 2025;27 (3).
Tanadi C, Pajala FB, Supranoto YTN, et al. Simethicone with or without N-acetylcysteine as premedication in esophagogastroduodenoscopy: a systematic review and meta-analysis. Ann Gastroenterol. 2025;38 (1):28-40.
Uedo N, Gotoda T, Yoshinaga S, et al. Differences in routine esophagogastroduodenoscopy between Japanese and international facilities: A questionnaire survey. Dig Endosc. 2016;28 Suppl 1:16-24.
Ferrari C, Tadros M. Enhancing the quality of upper gastrointestinal endoscopy: Current indicators and future trends. Gastroenterology Insights. 2023;15 (1):1-18.
Cuschieri S. The CONSORT statement. Saudi J Anaesth. 2019;13 (Suppl 1):S27-S30.
Lee GJ, Park SJ, Kim SJ, Kim HH, Park MI, Moon W. Effectiveness of premedication with pronase for visualization of the mucosa during endoscopy: A randomized, controlled trial. Clin Endosc. 2012;45 (2):161-4.
Liu X, Guan CT, Xue LY, et al. Effect of premedication on lesion detection rate and visualization of the mucosa during upper gastrointestinal endoscopy: a multicenter large sample randomized controlled double-blind study. Surg Endosc. 2018;32 (8):3548-56.
Manfredi G, Berte R, Iiritano E, et al. Premedication with simethicone and N-acetylcysteine for improving mucosal visibility during upper gastrointestinal endoscopy in a Western population. Endosc Int Open. 2021;9 (2):E190-E194.
Chang WK, Yeh MK, Hsu HC, et al. Efficacy of simethicone and N-acetylcysteine as premedication in improving visibility during upper endoscopy. J Gastroenterol Hepatol. 2014;29 (4):769-74.
Mahawongkajit P, Kanlerd A. A prospective randomized controlled trial comparing simethicone, N-acetylcysteine, sodium bicarbonate, and peppermint for visualization in upper gastrointestinal endoscopy. Surg Endosc. 2021;35 (1):303-8.
Zhang LY, Li WY, Ji M, et al. Efficacy and safety of using premedication with simethicone/Pronase during upper gastrointestinal endoscopy examination with sedation: A single center, prospective, single blinded, randomized controlled trial. Dig Endosc. 2018;30 (1):57-64.
Anikhindi SA, Kumar A, Uedo N, et al. Pre-endoscopy drink of simethicone and N-acetylcysteine significantly improves visualization in upper gastrointestinal endoscopy. Journal of Digestive Endoscopy. 2021;12 (01):011-8.
Shah I, Baffy NJ, Horsley-Silva JL, Langlais BT, Ruff KC. Peppermint oil to improve visualization in screening colonoscopy: A randomized controlled clinical trial. Gastroenterology Res. 2019;12 (3):141-7.
Burke E, Harkins P, Moriarty F, Ahmed I. Does premedication with mucolytic agents improve mucosal visualization during oesophagogastroduodenoscopy: A systematic review and meta-analysis. Surg Res Pract. 2021;2021:1570121.
Woo JG, Kim TO, Kim HJ, et al. Determination of the optimal time for premedication with pronase, dimethylpolysiloxane, and sodium bicarbonate for upper gastrointestinal endoscopy. J Clin Gastroenterol. 2013;47 (5):389-92.
Beg S, Ragunath K, Wyman A, et al. Quality standards in upper gastrointestinal endoscopy: a position statement of the British Society of Gastroenterology (BSG) and Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland (AUGIS). Gut 2017;66 (11):1886-99.
Beaufort IN, Verbeek RE, Bosman JH, et al. Optimal timing of simethicone administration prior to upper endoscopy: A multicenter, single-blind, randomized controlled trial. Endosc Int Open. 2023;11 (10): E992-E1000.
Bhandari P, Green S, Hamanaka H, et al. Use of gascon and pronase either as a pre-endoscopic drink or as targeted endoscopic flushes to improve visibility during gastroscopy: a prospective, randomized, controlled, blinded trial. Scand J Gastroenterol. 2010; 45 (3):357-61.
Carvalho AHC, Couto TdA, Carneiro MdV, Trevizoli JET, de Faria RJ, de Meneses J, Carvalho-Louro DM. A randomized, controlled study on the use of antifoaming and mucolytic agents in preparation for upper digestive endoscopy. 2024.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Fauzi Yusuf, Azzaki Abubakar, Desi Maghfirah
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright
The authors who publish in this journal agree to the following requirements:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)
Privacy Statement
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
